Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Golob-Schwarzl Nicole |
Präsentationen bei wissenschaftlichen und nicht-wissenschaftlichen Veranstaltungen
Golob-Schwarzl, N; Pilic, J; Vrebo, A; Reinprecht, C; Benezeder, T; Bordag, N; Painsi, C; Wolf,P.
Eukaryotic translation inititation Factor 4E (eIF4E) as a target of anti-psoriatic treatment
Spring School 2024 . 2024; -Spring School 2024; April 15 - 17, 2024; Copenhagen, DENMARK.
[Oral Communication]
Golob-Schwarzl, N; Perchthaler, I; Cerroni, L; Legat, FJ.
eIF4E: A new Diagnostic Tool for Mycosis Fungoides
ÖGDV Jahrestagung 2023. 2023; -ÖGDV Jahrestagung; NoV 30 - DEC 02, 2023; Salzburg, AUSTRIA.
[Poster]
Golob-Schwarzl, N; Pilic, J; Vrebo, A; Reinprecht, C; Benezeder, T; Bordag, N; Painsi, C; Wolf, P
Bricilib - a new strategy for the treatment of psoriasis targeting eukaryotic translation initiation factor 4E
J INVEST DERMATOL. 2023; 143(11):S341-S341.-5th Inflammatory Skin Disease Summit (ISDS); NOV 15-18, 2023; Vienna, AUSTRIA.
[Poster]
Web of Science
Zarfl, MR; Patra, V; Bordag, N; Quehenberger, F; Golob-Schwarzl, N; Gruber-Wackernagel, A; Wolf, P
Topical Disinfection Rebalances Impaired Cytokines in
Polymorphic Light Eruption: Implications to MicrobiotaDependent Immune Modulation
Sonderausgabe anlässlich der ÖGDV Jahrestagung 2023 in Salzburg
. 2023; 1: 72--ÖGDV Salzburg Congress; NOV 30 - DEZ 02, 2023; Salzburg, Austria.
[Poster]
FullText
Bordag, N; Pilic, J; Bourgeois, BMR; Madl, T; Wolf, P; Golob-Schwarzl, N
eIF1A and eIF3B as new treatment options in psoriasis: a metabolic perspective
ÖGDV Science Days 2022; SEP 15-17, 2022; Bad Gastein, Austria. 2022.
[Oral Communication]
Golob-Schwarzl, N; Pilic, J; Benezeder, T; Bordag, N; Painsi, C; Wolf, P
Eukaryotic translation initiation factor 4E (eIF4E) as a target of anti-psoriatic treatment
J INVEST DERMATOL. 2022; 142(12): S244-S244.
[Poster]
Web of Science
Golob-Schwarzl, N; Pilic, J; Benezeder, T; Bordag, N; Painsi, C; Wolf, P
ESDR374 - Eukaryotic translation initiation factor 4E (eIF4E) as a target of anti-psoriatic treatment
E-Poster European Society for Dermatological Research. 2022; -51st Annual ESDR Meeting; Sep 28-Oct 2, 2022; Amsterdam, Netherlands.
[Poster]
FullText
Golob-Schwarzl, N; Pilic, J; Benezeder, T; Painsi, C; Wolf, P
Eukaryotic Translation Initiation Factors (eIFs): Potential Therapeutic Targets in Psoriasis
4th Inflammatory Skin Disease Summit 2021. 2021; -4th Inflammatory Skin Disease Summit 2021; Nov 3 - 6, 2021; New York, USA.
[Poster]
Golob-Schwarzl, N; Pilic, J; Benezeder, T; Painsi, C; Wolf, P
Eukaryotic Translation Initiation Factors (eIFs): Potential Therapeutic Targets in Psoriasis
J INVEST DERMATOL. 2021; 141(10): S177-S177.
[Poster]
Web of Science
Golob-Schwarzl, N; Pilic, J; Benezeder, T; Painsi, C; Wolf, P
Eukaryotic Translation Initiation Factors (eIFs): Potential therapeutic targets in psoriasis
EXP DERMATOL. 2021; 30: 5-6.
[Oral Communication]
Web of Science
Golob-Schwarzl, N; Pilic, J; Benezeder, T; Painsi, C; Wolf,P
Eukaryotic Translation Initiation Factors (eIFs) as Potential Targets in Psoriasis
Science Days 2021. 2021; -Science Days ; Jun 25-26, 2021; Mondsee, Austria.
[Poster]
Leber, S; Krassnig, S; Birkl-Toeglhofer, A; Golob-Schwarzl, N; Wodlej, C; Flunkert, S; Hutter-Paier, B; Kalev, O; Weis, S; Haybaeck, J
Septin2 and 9 Alterations in Human Post mortem Alzheimer’s Disease Brains
Proceedings of The Lancet Summit, 2021. 2021; -The Lancet Summit: Presymptomatic Prevention and Treatment of Neurodegenerative Diseases; Dez 14 - 16, 2021; London (virtual).
[Poster]
Golob-Schwarzl, N; Pilic, J; Benezeder, T; Painsi, C; Wolf,P
Eukaryotic Translation Initiation Factors (eIFs): Potential Therapeutic Targets in Psoriasis.
ÖGDV Jahrestagung. 2020; -ÖGDV; DEC 4-5, 2020; Vienna, AUSTRIA.
[Onlinepräsentation]
Nicole Golob-Schwarzl, Johannes Pilic, Peter Wolf
Eukaryotic Translation Initiation Factors (eIFs) as Potential Targets in Psoriasis: Results of the Imiquimod (IMQ) Model.
Science Days 2020. 2020; -Science Days 2020; Jan 16-18, 2020; Mondsee, AUSTRIA.
[Oral Communication]
Leber, S; Johannes Haybaeck, Stefanie Kraßnig, Anna Töglhofer, Nicole Golob-Schwarzl, Christina Wodlej, Ognian Kalev, Serge Weis, Stephan Sygulla, Marlene Leoni, Stefanie Flunkert, Birgit Hutter-Paier
Septin2 and 9 as contributors to alzheimer's disease
Proceedings of the 4th Joint Annual Meeting of the Swiss and Austrian Societies of Pathology. 2019; -JOINT ANNUAL MEETING SGPATH-ÖGPATH-SSCYT 2019 ; 07 - 09 November 2019 ; Luzern.
[Poster]
Nicole Golob-Schwarzl, Johannes Pilic, Peter Wolf
Eukaryotic Translation Initiation Factors (eIFs) as Potential Targets in Psoriasis: Results of the Imiquimod (IMQ) Model
ÖGDV Jahrestagung 2019. 2019; -ÖGDV Jahrestagung 2019; Dec 5-7, 2019; Vienna, AUSTRIA.
[Poster]
Pilic, J; Golob-Schwarzl, N; Benezeder, T; Wolf, P
Expression of Eukaryotic Initiation Factors in Lesional Skin of Psoriasis Patients.
ÖGDV Jahrestagung 2019; DEC 5-7, 2019; Vienna, AUSTRIA. 2019.
[Poster]
Baehr, A; Krassnig, S; Schinlauer, A; Nass, N; Golob-Schwarzl, N; Wodlej, C; Raicht, A; Speicher, I; von Campe, G; Asslaber, M; Mawrin, C; Benesch, M; Haybaeck, J.
Eukaryotic initiation factors are differentially expressed in pediatric and adult medulloblastoma.
Neurowoche 2018; 91. Kongress der Deutschen Gesellschaft für Neurologie; OCT 30-NOV 3, 2018; Berlin, GERMANY. 2018.
[Poster]
Golob-Schwarzl, N; Wodlej, C; Kleinegger, F; Toeglhofer, AM; Krassnig, S; Thalhammer, M; Aigelsreiter, A; Hayback, J
Eukaryotic Translation Initiation Factors Might Represent a Potential Therapeutic Target for Gallbladder Cancer
ONCOL RES TREAT. 2018; 41: 68-68.-33. Deutscher Krebs Kongress; FEB 21-24, 2018; Berlin, GERMANY.
[Poster]
Web of Science
Golob-Schwarzl N,Krassnig S, Birkl -Toeglhofer A.M, Park Y.N, Gogg-Kamerer M, Puchas P, Vierlinger K, Schröder F, Schicho R, Fickert P, Haybaeck J
New liver cancer biomarkers: PI3K/AKT/mTOR pathway members and eukaryotic translation initiation factors
51. Jahrestagung der ÖGGH; Juni 14 - 16, 2018; Salzburg, AUSTRIA. 2018.
[Oral Communication]
Golob-Schwarzl N,Krassnig S, Birkl -Toeglhofer A.M, Park Y.N, Gogg-Kamerer M, Puchas P, Vierlinger K, Schröder F, Schicho R, Fickert P, Haybaeck J
New Liver Biomarker
102. Annual Meeting of the German Society of Pathology. 2018; -102. Annual Meeting of the German Society of Pathology; May, 2018; Berlin.
[Poster]
Herzl, A; Krassnig, S; Wodlej, C; Birkl-Toeglhofer, AM; Golob-Schwarzl, N; Kalev, O; Leoni, M; Sygulla, S; Weis, S; Haybaeck, J;
Inhibiting eIF4F-complex formation might be a novel therapeutic target in
Alzheimer’s disease
International Student Congress, ISC 2018; MAY 31- JUN 2, 2018; Graz, AUSTRIA. 2018.
[Poster]
Kleinegger, F; Wodlej, C; Golob-Schwarzl, N; Birkl-Töglhofer, AM; Krassnig, S; Niedrist, T; Thalhammer, M; Aigelsreiter, A; Rose-John, S; Fikert, P; Rinner, B; Haybäck, J;
Classic and Trans Interleukin-6 Signaling Promotes Cholangiocarcinoma
6th International Students Congress. 2018; -6th International Students Congress; MAY 31 - JUNE 2; Graz, AUSTRIA.
[Oral Communication]
Krassnig, S; Baehr, A; Schinlauer, A; Golob-Schwarzl, N; Wodlej, C; Raicht, A; Speicher, I; Poehlmann-Nitsche, A; Asslaber, M; Mawrin, C; Benesch, M; Haybaeck, J
Expression levels of eukaryotic initation factors are altered in paediatric medulloblastoma
Der Pathologe 39: 89-89. 2018; -102. Jahrestagung der Deutschen Gesellschaft für Pathologie; MAY 24-26, 2018; Berlin, GERMANY.
[Oral Communication]
FullText
Wodlej, C; Krassnig, S; Golob-Schwarzl, N; Herzl, A; Kleinegger, F; Birkl-Toeglhofer, AM; Gantenbein, N; Speicher, I; Singer, G; Till, H; Izycka-Swieszewska, E; Czapiewski, P; Haybaeck, J;
Die Rolle von eukaryotischen Translations-Initiationsfaktoren als potentielles neues therapeutisches Target beim Neuroblastom
Der Pathologe 39: 94-94. 2018; -102. Jahrestagung der Deutschen Gesellschaft für Pathologie; MAY 24-26,2018; Berlin, GERMANY.
[Oral Communication]
FullText
Wodlej, C; Krassnig, S; Golob-Schwarzl, N; Kleinegger, F; Birkl-Toeglhofer, AM; Herzl, A; Singer, G; Toll, H; Izycka-Swieszewska, E; Czapiewski, P; Haybaeck, J
Eukaryotic Initiation Factor 4A1 as Potential Therapeutic Target in Neuroblastoma
Proceedings of the Doctoral Day. 2018; -Doctoral Day 2018; NOV 28, 2018; Graz, AUSTRIA.
[Poster]
Wodlej, C; Krassnig, S; Golob-Schwarzl, N; Kleinegger, F; Toeglhofer, AM; Sygulla, S; Singer, G; Till, H; Izycka-Swieszewska, E; Czapiewski, P; Hayback, J
The Role of Eukaryotic Translation Initiation Factors as Potential Targets in Neuroblastoma
ONCOL RES TREAT. 2018; 41: 131-131.-33. Deutscher Krebs Kongress; FEB, 21-24, 2018; Berlin, GERMANY.
[Poster]
Web of Science
Gantenbein, N; Bernhart, E; Anders, I; Golob-Schwarzl, N; Gogg-Kamerer, M; Lindenmann, J; Fink-Neuboeck, N; Brcic, L; Gollowitsch, F; Stacher-Priehse, E; Rolff, J; Hoffmann, J; Silverstri, A; Regenbrecht, C; Reinhard, C; Pehserl, AM; Pichler, M; Mitterer, V; Pertschy, B; Bergler, H; Popper, H; Sattler, W; Haybaeck, J..
Eukaryotic Translation Initiation Factors impact Non Small Cell Lung Cancer
European Congress of Pathology; Sep 2.-6., 2017; Amsterdam. 2017.
[Poster]
Gantenbein, N; Bernhart, E; Anders, I; Golob-Schwarzl, N; Gogg-Kammerer, M; Lindenmann, J; Fink-Neuboeck, N; Brcic, L; Gollowitsch, F; Stacher-Priehse, E; Rolff, J; Hoffmann, J; Silvestri, A; Regenbrecht, C; Reinhard, C; Pehserl, AM; Pichler, M; Mitterer, V; Pertschy, B; Bergler, H; Popper, H; Sattler, W; Haybaeck, J
Eukaryotic translation initiation factors impact non small cell lung cancer
VIRCHOWS ARCH. 2017; 471: S104-S104.
[Poster]
Web of Science
Gantenbein, N; Bernhart, E; Anders, I; Golob-Schwarzl, N; Lindenmann, J; Fink-Neuboeck, N; Brcic, L; Gollowitsch, F; Stacher-Priehse, E; Rolff, J; Hoffmann, J; Reinhard, C; Popper, H; Sattler, W; Haybaeck, J.
Eukaryotic Translation Initiation Factors trigger Non Small Cell Lung Cancer (NSCLC)
International Student Congress; May 25-27, 2017; Graz. 2017.
[Oral Communication]
Gantenbein,N; Bernhart,E; Anders,I; Golob-Schwarzl,N; Lindenmann,J; Fink-Neuböck,N; Brcic,L; Gollowitsch,F; Stacher-Priehse,E; Rolff,J; Hoffmann,J; Silvestri,A; Reinhard,C; Pehserl,AM; Pichler,M; Mitterer,V; Pertschy,P; Bergler,B; Popper,H; Sattler,W; Haybaeck,J
Eukaryotic Translation Initiation Factors impact Non Small Cell Lung Cancer
CBmed Biomarker Conference; 13.2.2017; Graz, AUSTRIA. 2017.
[Poster]
Golob-Schwarzl N, Krassnig S, Toeglhofer AM, Park YN, Gogg-Kamerer M, Vierlinger K, Schröder F, Rhee H, Schicho R, Fickert P, Haybaeck J
New liver cancer biomarkers: PI3K/AKT/mTOR pathway members and eukaryotic translation initiation factors
2017. 2017; -European Congress of Pathology; Sep 2.-6., 2017; Amsterdam.
[Poster]
Golob-Schwarzl, N; Schweiger, C; Koller, C; Kraßnig, S; Gogg-Kamerer, M; Gantenbein, N; Bergler, H; Pertschy, B; M; Uranitsch, S; Lackner, K; Punschart, A; Stiegler, P; Keil, M; Hoffmann, J; Henderson, D; Lehrach, H; Reinhard, CH; Schicho, R; Fickert, P; Lax, S; Haybaeck, J
Eukaryotic initiation factors (eIFs) in colorectal carcinoma
European Cancer Congress; Jan 27 - 30, 2017; Amsterdam. 2017.
[Poster]
Golob-Schwarzl, N; Schweiger, C; Koller, C; Kraßnig, S; Gogg-Kamerer, M; Gantenbein, N; Bergler, H; Pertschy, B; M; Uranitsch, S; Lackner, K; Punschart, A; Stiegler, P; Keil, M; Hoffmann, J; Henderson, D; Lehrach, H;Regenbrecht,C; Reinhard, CH; Schicho, R; Fickert, P; Lax, S; Haybaeck, J,
Eukaryotic Initiation factors (eIFs) in colorectal carcinoma
19th International AEK Cancer Congress 2017 ; 1 – 3 March 2017 ; Heidelberg, GERMANY. 2017.
[Poster]
Kleinegger, F; Golob-Schwarzl, N; Toeglhofer, AM; Baran, P; Krassnig, S; Niedrist, T; Speicher, I; Rinner, B; Thalhammer, M; Aigelsreiter, A; Lackner, C; Scheller, J; Rose-John, S; Fickert, P; Haybaeck, J
Interleukin-6 Receptor influences cholangiocarcinoma progression
VIRCHOWS ARCH. 2017; 471: S325-S326.-29th European Congress of Pathology; SEP 2-6, 2017; Amsterdam, The Netherlands.
[Poster]
Web of Science
Kleinegger, F; Golob-Schwarzl, N; Toeglhofer, AM; Krassnig, S; Niedrist, T; Speicher, I; Rinner, B; Thalhammer, M; Aigelsreiter, A; Lackner, C; Rose-John, S; Fickert, P; Haybaeck, J;
Die Expression des Interleukin 6 Rezeptors hat Auswirkungen auf das Cholangiozelluläre Karzinom.
101. Jahrestagung der deutschen Gesellschaft für Pathologie . 2017; JUN 22-24; Erlangen, GERMANY.
[Poster]
Kleinegger, F; Wodlej, C; Golob-Schwarzl, N; Birkl-Toeglhofer, AM; Baran, P; Krassnig, S; Niedrist, T; Rinner, B; Thalhammer, M; Aigelsreiter, A; Scheller, J; Rose-John, S; Fickert, P; Haybaeck, J;
The Role of Interleukin-6 Receptor Signaling in Cholangiocarcinoma
Proceedings of the Doctoral Day. 2017; -Proceedings of the Doctoral Day.; DEC 13, 2017; Graz, Austria.
[Poster]
Krassnig, S; Orthmann, A; Toeglhofer, AM; Wohlrab, C; Golob-Schwarzl, N; Wodlej, C; Pennauer, M; Raicht, A; Ali, KM; von Campe, G; Gogg-Kamerer, M; Logi, M; Sygulla, S; Hoffmann, J; Weis, S; Benesch, M; Haybaeck, J
Eukaryotic initiation factors might not only represent novel targets for glioma therapies but might also monitor drug effectiveness
VIRCHOWS ARCH. 2017; 471: S46-S46.
[Oral Communication]
Web of Science
Krassnig, S; Toeglhofer, AM; Golob-Schwarzl, N; Wodlej, C; Birkl, C; Kalev, O; Sygulla, S; Leoni, M; Weis, S; Haybaeck, J;
Alterations in the expression levels of eukaryotic initiation factors in Alzheimer’s disease
Der Pathologe Ausgabe 5/2017. 2017; -Herbsttagung der ÖGPath/IAP 2017; SEP 14-16, 2017; Velden, AUSTRIA.
[Poster]
Krassnig, S; Toeglhofer, AM; Golob-Schwarzl, N; Wodlej, C; Kalev, O; Leoni, M; Flunkert, S; Hutter-Paier, B; Weis, S; Haybaeck, J
Eukaryotic initiation factor 4G (eIF4G) is altered in Alzheimer’s disease and might therefore be involved in pathological mechanisms
Proceedings of the 13th International Conference on Alzheimer's and Parkinson's Diseases.. 2017; -13th International Conference on Alzheimer's and Parkinson's Diseases; MAR 29-APR 2; Vienna, AUSTRIA.
[Poster]
Krassnig, S; Wohlrab, C; Orthmann, A;Golob-Schwarzl, N; Toeglhofer, A; Wodlej, C; Pennauer, M; Raicht, A; Mahdy Ali, M; Von Campe, G; Leoni, M; Sygulla, S; Hoffmann, J; Weis, S; Benesch, M; Haybaeck, J .
Eukaryotische Initiationsfaktoren stellen ein potenzielles neues therapeutisches Target für die Behandlung von Gliomen dar
101. Jahrestagung der deutschen Gesellschaft für Pathologie ; JUN 22-24; Erlangen, GERMANY. 2017.
[Poster]
Krassnig, S;Orthmann, A; Wohlrab, C; Golob-Schwarzl, N; Toeglhofer, A; Wodlej, C; Pennauer, M; Raicht, A; Mahdy Ali, M; Von Campe, G; Gogg-Kamerer, M; Leoni, M; Sygulla, S; Hoffmann, J; Weis, S; Benesch, M; Haybaeck, J
Eukaryotic initiation factors might represent a novel marker to monitor the effectiveness of glioma therapy.
Brain Tumor Meeting 2017; May 18-19, 2017; Berlin, GERMANY. 2017.
[Poster]
Toeglhofer AM, Krassnig S, Golob-Schwarzl N, Kalev O, Leoni M, Wodlej C, Weis S, Haybaeck J
Alterations in eukaryotic translation initiation might contribute to Parkinson’s disease pathology
Proceedings of the 13th International Conference on Alzheimer's and Parkinson's Diseases. 2017; -13th International Conference on Alzheimer's and Parkinson's Diseases; MAR 29-APR 2; Vienna, AUSTRIA.
[Poster]
Toeglhofer, AM; Krassnig, S; Golob-Schwarzl, N; Wodlej, C; Birkl, C; Kalev, O; Leoni, M; Flunkert, S; Hutter-Paier, B; Weis, S; Haybaeck, J
Eukaryotic initiation factors are altered in Alzheimer's disease
VIRCHOWS ARCH. 2017; 471: S218-S219.
[Poster]
Web of Science
Toeglhofer, AM; Krassnig, S; Golob-Schwarzl, N; Wodlej, C; Birkl, C; Kalev, O; Leoni, M; Flunkert, S; Hutter-Paier, B; Weis, S; Haybaeck, J;
Eukaryotic initiation factors are altered in Alzheimer’s disease.
Proceedings of the 29th European Congress of Pathology. 2017; -29th European Congress of Pathology; SEP 2-6, 2017; Amsterdam, THE NETHERLANDS.
[Poster]
Wodlej, C; Krassnig, S; Golob-Schwarzl, N; Kleinegger, F; Birkl-Toeglhofer, AM; Sygulla, S; Singer, G; Till, H; Izycka-Swieszewska, E; Czapiewski, P; Haybaeck, J
Eukaryotic Translation Initiation Factors and Their Potential Role as Targets in Neuroblastoma
Proceedings of the Doctoral Day. 2017; -Doctoral Day; 13.12.2017; Graz, AUSTRIA.
[Poster]
Wodlej, C; Krassnig,S; Golob-Schwarzl, N; Sygulla, S; Singer, G; Till, H; Izycka-Swieszewska, E; Czapiewski, P; Haybaeck, J
Eukaryotic Translation Initiation Factors Might Represent Novel Targets in Neuroblastoma
International Student Congress (ISC); MAY 25-27, 2017; Graz, AUSTRIA. 2017.
[Oral Communication]
Golob-Schwarzl, N; Schweiger, C; Koller, C; Krassnig, S; Gogg-Kamerer, Gantenbein, N; Bergler, H; Pertschy, B; M; Uranitsch, S; Lackner, K; Punschart, A, Stiegler, P; Keil, M; Hoffmann, J; Henderson, D; Lehrach, H; Reinhard, CH; Schicho, R; Fickert, P; Lax, S; Haybaeck, J
Translation Initiation separates low and high grade and colon and rectum carcinoma
Doctoral Day ; 2016; Graz, AUSTRIA. 2016.
[Oral Communication]
Kuscuoglu, D; Wenzel, K; Ensari, GK; Golob-Schwarzl, N; Hittatiya, K; Fischer, HP; Haybaeck, J; Trautwein, C; Strnad, P
Accumulation of hepatitis B surface antigen promotes the development of A1AT mutation-related liver disease
Journal of Hepatology 2016, Abstract Book. 2016; 64: 298--The International Liver Conference 2016; APR 13-17, 2016; Barcelona, SPAIN.
[Oral Communication]
Kuscuoglu, D; Wenzel, K; Ensari, GK; Golob-Schwarzl, N; Hittatiya, K; Fischer, HP; Haybaeck, J; Trautwein, C; Strnad, P
HSP72 OVEREXPRESSION PROTECTS FROM LIVER INJURY VIA ATTENUATION OF JNK SIGNALLING
Journal of Hepatology 2016, Abstract Book. 2016; 170--The International Liver Conference 2016; APR 13-17, 2016; Barcelona, SPAIN.
[Poster]
Orthmann, A; Hoffmann, A; Ernst, C; Golob-Schwarzl, N; Krassnig, S; Haybaeck, J; Jodicke, A; Kuhn, S; Linnebacher, M; Fichtner, I; Hoffmann, J
Therapeutic response to chemotherapeutic drugs of glioma-PDX and correlation to common mutations identified by panel sequencing
ONCOL RES TREAT. 2016; 39: 160-160.
[Oral Communication]
Web of Science
Anders, I; Asslaber, M; Golob-Schwarzl, N; Halbwedl, I; Gogg-Kamerer, M; Al-Effah, M; Hoffmann, J; Rolff, J; Popper, H; Haybaeck, J
Particular components of the translation machinery drive lung cancer formation
VIRCHOWS ARCH. 2015; 467: S258-S258.
[Poster]
Web of Science
Anders, I; Asslaber, M; Golob-Schwarzl, N; Halbwedl, I; Gogg‑Kamerer, M; Al-Effah, M; Hoffmann, J; Rolff, J; Popper, H; Haybaeck, J
Particular components of the translation machinery drive lung cancer formation
. 2015; -3rd International Student Congress; JUN 3-5, 2015; Graz, AUSTRIA.
[Oral Communication]
Birkl, C; Langkammer, C; Golob-Schwarzl, N; Leoni, M; Haybaeck, J; Goessler, W; Fazekas, F; Ropele, S;
Effects of formalin fixation on MR relaxation times in the human brain
Proceedings of the ISMRM 23rd Annual Meeting. 2015; -ISMRM 23rd Annual Meeting; MAY 30 - JUN 5, 2015; Toronto, Canada.
[Poster]
Ernst, C; Krassnig, S; Golob-Schwarzl, N; Asslaber, M; Raicht, A; Lederer, E; Spilka, R; Von Campe, G; Orthmann, A; Hoffmann, J; Weis, S; Benesch, M; Haybaeck, J
Eukaryotic initiation factors and their contribution to gliomas might be relevant for the development of new therapies
VIRCHOWS ARCH. . 2015; 467: S40-S40.
[Oral Communication]
Web of Science
Golob-Schwarzl, N; Schweiger, C; Koller, C; Gogg-Kamerer, M; Uranitsch, S; Lackner, C; Punschart, A; Stiegler, P; Keil, M; Hoffmann, J; Henderson, D; Lehrach, H; Hoyle, N; Reinhard, C; Lax, S; Haybaeck, J
Eukaryotic translation initiation factors are overexpressed in colorectal carcinoma compared to -normal colorectalmucosa: Impact on the RTK/PI3K/Akt-mTOR pathway and putative therapeutic targets
VIRCHOWS ARCH. 2015; 467: S8-S8.
[Oral Communication]
Web of Science
Golob-Schwarzl, N; Schweiger, C; Koller, C; Gogg-Kamerer, M; Uranitsch, S; Lackner, C; Punschart, A; Stiegler, P; Keil, M; Hoffmann, J; Henderson, D; Lehrach, H; Hoyle, N; Reinhard, C; Lax, S; Haybaeck, J
Modulation of eukaryotic translation initiation factor expression in colorectal carcinoma by cytostatic and targeted medication as demonstrated in xenograft models
VIRCHOWS ARCH. 2015; 467: S166-S166.
[Poster]
Web of Science
Golob-Schwarzl, N; Schweiger, C; Koller, C; Gogg-Kamerer, M; Uranitsch, S; Lackner, K; Punschart, A, Stiegler, P; Keil, M; Hoffmann, J; Henderson, D; Lehrach, H; Reinhard, CH; Lax, S; Haybaeck, J
Eukaryotic Translation Initiation Factors are overexpressed in Colorectal Carcinoma compared to Normal Colorectal Mucosa: Impact on the RTK/PI3K/Akt-mTor pathway and putative therapeutic targets
27th European Congress of Pathology, Belgrad; 2015; Belgrad, SERBIA. 2015.
[Oral Communication]
Golob-Schwarzl, N; Schweiger, C; Koller, C; Gogg-Kamerer, M; Uranitsch, S; Lackner, K; Punschart, A, Stiegler, P; Keil, M; Hoffmann, J; Henderson, D; Lehrach, H; Reinhard, CH; Lax, S; Haybaeck, J
Modulation of eukaryotic translation initiation factor expression in colorectal carcinoma by cytostatic and targeted medication as demonstrated in xenograft models
Doc Day; 2015; Graz, AUSTRIA. 2015.
[Poster]
Golob-Schwarzl, N; Schweiger, C; Koller, C; Gogg-Kamerer, M; Uranitsch, S; Lackner, K; Punschart, A, Stiegler, P; Keil, M; Hoffmann, J; Henderson, D; Lehrach, H; Reinhard, CH; Lax, S; Haybaeck, J
Modulation of the Eukaryotic Translation Initiation Factor Expression in Colorectal Carcinoma by cytostatic and targeted medication as demonstrated on xenograft models
27th European Congress of Pathology; 2015; Belgrad, SERBIA. 2015.
[Poster]
Golob-Schwarzl, N; Schweiger, C; Koller, C; Gogg-Kamerer, M; Uranitsch, S; Lackner, K; Punschart, A, Stiegler, P; Keil, M; Hoffmann, J; Henderson, D; Lehrach, H; Reinhard, CH; Lax, S; Haybaeck, J
Eukaryotic Initiation Factors are critically involved in the formation and progression of Colorectal Cancer
International Student Congress; Graz, AUSTRIA. 2015.
[Oral Communication]
Golob-Schwarzl, N; Schweiger, C; Koller, C; Gogg-Kamerer, M; Uranitsch, S; Lackner, K; Punschart, A, Stiegler, P; Keil, M; Hoffmann, J; Henderson, D; Lehrach, H; Reinhard, CH; Lax, S; Haybaeck, J
Eukaryotic Translation Initiation Factors are overexpressed in colorectal carcinoma compared to normal colorectal mucosa on the impact on the RTK/PI3K/Akt-mTOR pathway
Doctoral Day; 2015; Graz, AUSTRIA. 2015.
[Oral Communication]
Lederer, E; Petzold, J; Rehis, R; Ernst, C; Bettermann, K; Golob-Schwarzl, N; Moriggl, R; Schlederer, M; Lax, S; Hoffmann, J; Haybaek, J
The role of the JAK/STAT pathway in gallbladder cancer
VIRCHOWS ARCH. 2015; 467: S3-S3.
[Oral Communication]
Web of Science